Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.
Browsing: Marius Pharmaceuticals
From nutrition and sleep to peptides and regenerative medicine, here’s how to build a long life you can actually sustain.
Marius Pharmaceuticals, which helped secure FDA removal of Black Box Warning, says regulatory shift marks a milestone for patient access and treatment options.
From Novavax to global equities, Raleigh, NC -based Shah Capital’s founder shares his investment philosophy and strategy
The campaign seeks to illuminate the impact of testosterone deficiency on men’s health.
Kyzatrex could be a potential blockbuster to treat testosterone deficiency, a severely undertreated disease. Â